| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |